Search

Your search keyword '"Tyrer, Jonathan P"' showing total 557 results

Search Constraints

Start Over You searched for: Author "Tyrer, Jonathan P" Remove constraint Author: "Tyrer, Jonathan P"
557 results on '"Tyrer, Jonathan P"'

Search Results

151. Shared heritability and functional enrichment across six solid cancers

152. A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome‐wide significant common variants

153. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes

154. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

155. Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene

156. Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores

157. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

158. Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer

159. Identification of nine new susceptibility loci for endometrial cancer

160. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility

161. Genetic overlap between endometriosis and endometrial cancer: evidence from cross‐disease genetic correlation and GWAS meta‐analyses

162. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.

163. Population-based targeted sequencing of 54 candidate genes identifies PALB2as a susceptibility gene for high-grade serous ovarian cancer

164. CYP19A1 fine-mapping and Mendelian randomization

165. Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations

166. Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium

167. The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study

168. Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer

169. Genetic Risk Score Mendelian Randomization Shows that Obesity Measured as Body Mass Index, but not Waist:Hip Ratio, Is Causal for Endometrial Cancer

170. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk

171. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

172. Candidate locus analysis of the TERT–CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk

173. The Influence of Age and Sex on Genetic Associations with Adult Body Size and Shape: A Large-Scale Genome-Wide Interaction Study

174. CYP19A1 fine-mapping and Mendelian randomization: estradiol is causal for endometrial cancer

175. Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer

176. Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population

177. Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer

178. Abstract POSTER-CTRL-1213: Whole exome and targeted resequencing, of population based ovarian cancer cases and controls, identifies susceptibility genes for ovarian cancer

179. Prediction of Breast and Prostate Cancer Risks inMale BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores.

180. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.

181. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci

182. Evaluation of polygenic risk scores for ovarian cancer risk prediction in a prospective cohort study

183. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer

185. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

186. Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk

187. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

188. Author Correction: Exome sequencing identifies breast cancer susceptibility genes and defines the contribution of coding variants to breast cancer risk

189. Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci

190. Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers.

191. Five endometrial cancer risk loci identified through genome-wide association analysis

192. Association analysis identifies 65 new breast cancer risk loci

193. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer

194. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC)

195. Rare and low-frequency coding variants alter human adult height

196. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS

197. Gene Set Analysis of Survival Following Ovarian Cancer Implicates Macrolide Binding and Intracellular Signaling Genes.

198. No Association between TERT-CLPTM1L Single Nucleotide Polymorphism rs401681 and Mean Telomere Length or Cancer Risk.

199. Common Single-Nucleotide Polymorphisms in DNA Double-Strand Break Repair Genes and Breast Cancer Risk.

200. Common variants at theCHEK2gene locus and risk of epithelial ovarian cancer

Catalog

Books, media, physical & digital resources